Long-Term Liabilities: The sum of all non-current liabilities.
OnKure Therapeutics, Inc. (OKUR) had Long-Term Liabilities of $0.31M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-15.39M |
|
-- |
|
-- |
|
$16.32M |
|
$-16.32M |
|
$0.93M |
|
$-15.39M |
|
$-15.39M |
|
$-15.39M |
|
$-15.39M |
|
$-15.39M |
|
$-15.39M |
|
$-16.32M |
|
$-16.11M |
|
13.51M |
|
13.51M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$84.55M |
|
$0.82M |
|
$1.52M |
|
$86.07M |
|
$7.60M |
|
-- |
|
|
Long-Term Liabilities |
$0.31M |
$7.90M |
|
$78.17M |
|
$78.17M |
|
$78.17M |
|
13.53M |
|
| Cash Flow Statement Financials | |
$-27.28M |
|
$-0.03M |
|
$-0.08M |
|
$110.76M |
|
$83.37M |
|
$-27.39M |
|
$5.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.69% |
|
-19.69% |
|
-17.88% |
|
-19.69% |
|
$5.78 |
|
$-2.02 |
|
$-2.02 |
|